Activation of mammalian Toll-like receptors by endogenous agonists

被引:115
|
作者
Johnson, GB [1 ]
Brunn, GJ [1 ]
Platt, JL [1 ]
机构
[1] Mayo Clin & Mayo Fdn, Rochester, MN 55905 USA
关键词
inflammation; polysaccharides; Toll; endogenous; immunology; innate immunity; mammalian; Toll-like receptors; heparan sulfate; hyaluronic acid; lipopolysaccharide; necrosis; matrix; infection; R genes; Drosophila; enzymatic cascades; coagulation; degradation; pathogen-associated molecular patterns; surveillance; adaptive immunity; metastasis; ischemia; atherosclerosis; LIPOPOLYSACCHARIDE-BINDING PROTEIN; DORSAL-VENTRAL POLARITY; TUMOR-NECROSIS-FACTOR; HEAT-SHOCK PROTEINS; NF-KAPPA-B; INNATE IMMUNE RECOGNITION; GRAM-NEGATIVE BACTERIA; SUBENDOTHELIAL EXTRACELLULAR-MATRIX; HEPARAN-SULFATE PROTEOGLYCANS; MIMETIC SIGNAL-TRANSDUCTION;
D O I
10.1615/CritRevImmunol.v23.i12.20
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Toll-like receptors activate innate and adaptive immune systems in mammals. This ancient family of receptors has been evolving since before the taxonomic split between the plant and animal kingdoms. The discovery of the mammalian Toll-like receptors was heralded as confirmation of a predicted biological system explicitly designed to detect exogenous molecules from micro-organisms. However, there is accumulating evidence that Toll-like receptors also detect endogenous agonists, such as the degradation products of macromolecules, products of proteolytic cascades, intracellular components of ruptured cells, and products of genes that are activated by inflammation. Here we review endogenous models of Toll-like receptor activation, a subject of extensive debate. Endogenous activation of mammalian Toll-like receptors may provide key insights for the treatment of multiple conditions, from atherosclerosis to transplant rejection.
引用
收藏
页码:15 / 44
页数:30
相关论文
共 50 条
  • [1] Toll-Like Receptors in Atherosclerosis
    Falck-Hansen, Mika
    Kassiteridi, Christina
    Monaco, Claudia
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2013, 14 (07) : 14008 - 14023
  • [2] A Clear and Present Danger: Endogenous Ligands of Toll-like Receptors
    Jacob A. Sloane
    Daina Blitz
    Zachary Margolin
    Timothy Vartanian
    NeuroMolecular Medicine, 2010, 12 : 149 - 163
  • [3] A Clear and Present Danger: Endogenous Ligands of Toll-like Receptors
    Sloane, Jacob A.
    Blitz, Daina
    Margolin, Zachary
    Vartanian, Timothy
    NEUROMOLECULAR MEDICINE, 2010, 12 (02) : 149 - 163
  • [4] Toll-Like Receptors, Their Ligands, and Atherosclerosis
    Hodgkinson, Conrad P.
    Ye, Shu
    THESCIENTIFICWORLDJOURNAL, 2011, 11 : 437 - 453
  • [5] Toll-like receptors in kidney disease
    Smith, Kelly D.
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2009, 18 (03) : 189 - 196
  • [6] Toll-like receptors and macrophage activation in atherosclerosis
    Seneviratne, Anusha N.
    Sivagurunathan, Bawani
    Monaco, Claudia
    CLINICA CHIMICA ACTA, 2012, 413 (1-2) : 3 - 14
  • [7] Human Endogenous Retroviruses and Toll-Like Receptors
    Jin, Xinyi
    Li, Xueyuan
    Guan, Fang
    Zhang, Jianhua
    VIRAL IMMUNOLOGY, 2023, 36 (02) : 73 - 82
  • [8] Toll-like receptors
    Muzio, M
    Mantovani, A
    MICROBES AND INFECTION, 2000, 2 (03) : 251 - 255
  • [9] Toll-like receptors
    Lien, E
    Ingalls, RR
    CRITICAL CARE MEDICINE, 2002, 30 (01) : S1 - S11
  • [10] Endogenous ligands of toll-like receptors
    Tsan, MF
    Gao, BC
    JOURNAL OF LEUKOCYTE BIOLOGY, 2004, 76 (03) : 514 - 519